Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial von Goldschmidt, H, Lokhorst, H M, Mai, E K, van der Holt, B, Blau, I W, Zweegman, S, Weisel, K C, Vellenga, E, Pfreundschuh, M, Kersten, M J, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, M S, Broijl, A, Lindemann, H W, Bos, G M J, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, R M, Bertsch, U, Hielscher, T, Jarari, Le, Salwender, H J, Sonneveld, P

Volltext

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma von Mai, E K, Bertsch, U, Dürig, J, Kunz, C, Haenel, M, Blau, I W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M S, Neben, K, Lindemann, H-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I G H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Volltext

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial von Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G H, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment von Gratwohl, A, Pfirrmann, M, Zander, A, Kröger, N, Beelen, D, Novotny, J, Nerl, C, Scheid, C, Spiekermann, K, Mayer, J, Sayer, H G, Falge, C, Bunjes, D, Döhner, H, Ganser, A, Schmidt-Wolf, I, Schwerdtfeger, R, Baurmann, H, Kuse, R, Schmitz, N, Wehmeier, A, Th Fischer, J, Ho, A D, Wilhelm, M, Goebeler, M-E, Lindemann, H W, Bormann, M, Hertenstein, B, Schlimok, G, Baerlocher, G M, Aul, C, Pfreundschuh, M, Fabian, M, Staib, P, Edinger, M, Schatz, M, Fauser, A, Arnold, R, Kindler, T, Wulf, G, Rosselet, A, Hellmann, A, Schäfer, E, Prümmer, O, Schenk, M, Hasford, J, Heimpel, H, Hossfeld, D K, Kolb, H-J, Büsche, G, Haferlach, C, Schnittger, S, Müller, M C, Reiter, A, Berger, U, Saußele, S, Hochhaus, A, Hehlmann, R

Volltext

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants von Hehlmann, R, Lauseker, M, Saußele, S, Pfirrmann, M, Krause, S, Kolb, H J, Neubauer, A, Hossfeld, D K, Nerl, C, Gratwohl, A, Baerlocher, G M, Heim, D, Brümmendorf, T H, Fabarius, A, Haferlach, C, Schlegelberger, B, Müller, M C, Jeromin, S, Proetel, U, Kohlbrenner, K, Voskanyan, A, Rinaldetti, S, Seifarth, W, Spieß, B, Balleisen, L, Goebeler, M C, Hänel, M, Ho, A, Dengler, J, Falge, C, Kanz, L, Kremers, S, Burchert, A, Kneba, M, Stegelmann, F, Köhne, C A, Lindemann, H W, Waller, C F, Pfreundschuh, M, Spiekermann, K, Berdel, W E, Müller, L, Edinger, M, Mayer, J, Beelen, D W, Bentz, M, Link, H, Hertenstein, B, Fuchs, R, Wernli, M, Schlegel, F, Schlag, R, de Wit, M, Trümper, L, Hebart, H, Hahn, M, Thomalla, J, Scheid, C, Schafhausen, P, Verbeek, W, Eckart, M J, Gassmann, W, Pezzutto, A, Schenk, M, Brossart, P, Geer, T, Bildat, S, Schäfer, E, Hochhaus, A, Hasford, J

Volltext

High-risk additional chromosomal abnormalities at low blast counts herald death by CML von Hehlmann, Rüdiger, Voskanyan, Astghik, Lauseker, Michael, Pfirrmann, Markus, Kalmanti, Lida, Rinaldetti, Sebastien, Kohlbrenner, Katharina, Haferlach, Claudia, Schlegelberger, Brigitte, Fabarius, Alice, Seifarth, Wolfgang, Spieß, Birgit, Wuchter, Patrick, Krause, Stefan, Kolb, Hans-Jochem, Neubauer, Andreas, Hossfeld, Dieter K., Nerl, Christoph, Gratwohl, Alois, Baerlocher, Gabriela M., Burchert, Andreas, Brümmendorf, Tim H., Hasford, Jörg, Hochhaus, Andreas, Saußele, Susanne, Baccarani, Michele

Volltext

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-labe... von Schmitz, Norbert, Prof, Nickelsen, Maike, MD, Ziepert, Marita, PhD, Haenel, Mathias, MD, Borchmann, Peter, MD, Schmidt, Christian, MD, Viardot, Andreas, MD, Bentz, Martin, MD, Peter, Norma, MD, Ehninger, Gerhard, Prof, Doelken, Gottfried, Prof, Ruebe, Christian, Prof, Truemper, Lorenz, Prof, Rosenwald, Andreas, Prof, Pfreundschuh, Michael, Prof, Loeffler, Markus, Prof, Glass, Bertram, MD

Volltext

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial von Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML von Hehlmann, Rüdiger, Voskanyan, Astghik, Lauseker, Michael, Pfirrmann, Markus, Kalmanti, Lida, Rinaldetti, Sebastien, Kohlbrenner, Katharina, Haferlach, Claudia, Schlegelberger, Brigitte, Fabarius, Alice, Seifarth, Wolfgang, Spieß, Birgit, Wuchter, Patrick, Krause, Stefan, Kolb, Hans-Jochem, Neubauer, Andreas, Hossfeld, Dieter K., Nerl, Christoph, Gratwohl, Alois, Baerlocher, Gabriela M., Burchert, Andreas, Brümmendorf, Tim H., Hasford, Jörg, Hochhaus, Andreas, Saußele, Susanne, Baccarani, Michele

Volltext

Phase III trial of bortezomib, cyclophosphamide and dexamethasone in newly diagnosed myeloma von Mai, E.K, Bertsch, U, Durig, J, Kunz, C, Haenel, M, Blau, I.W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M.S, Neben, K, Lindemann, H.-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I.G.H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Volltext

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma von Merz, Maximilian, Jauch, Anna, Hielscher, Thomas, Bochtler, Tilmann, Schönland, Stefan Olaf, Seckinger, Anja, Hose, Dirk, Bertsch, Uta, Neben, Kai, Raab, Marc Steffen, Hillengass, Jens, Salwender, Hans, Blau, Igor Wolfgang, Lindemann, Hans-Walter, Schmidt-Wolf, Ingo G.H., Scheid, Christof, Haenel, Mathias, Weisel, Katja C., Goldschmidt, Hartmut

Volltext

A Predictive Score for Early Mortality during Induction Therapy in Newly Diagnosed Transplant-Eligible Multiple Myeloma - an Analysis from Five GMMG and HOVON Multicenter Phase III... von Mai, Elias K, Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans Jürgen, Lokhorst, Henk M, Munder, Markus, van der Holt, Bronno, Gerecke, Christian, Pfreundschuh, Michael, Duhrsen, Ulrich, Brossart, Peter, Zweegman, Sonja, Neben, Kai, Hillengass, Jens, Raab, Marc-Steffen S, Hose, Dirk, Vellenga, Edo, Merz, Maximilian, Breitkreutz, Iris, Jauch, Anna, Kersten, Marie José, Martin, Hans, Lindemann, Hans-Walter, Peter, Norma, Croockewit, Sandra, Blau, Igor Wolfgang, Scheid, Christof, Weisel, Katja C., Sonneveld, Pieter, Goldschmidt, Hartmut

Volltext

PF597 HIGH DOSE MELPHALAN (200MG/M2) AND AUTOLOGOUS TRANSPLANTATION IN NEWLY‐DIAGNOSED MULTIPLE MYELOMA UP TO THE AGE OF 70 YEARS: A SUBGROUP ANALYSIS FROM THE PHASE III GMMG‐MM5 T... von Mai, E.K., Miah, K., Merz, M., Dürig, J., Scheid, C., Weisel, K.C., Kunz, C., Bertsch, U., Munder, M., Lindemann, H.‐W., Hose, D., Jauch, A., Seckinger, A., Luntz, S., Sauer, S., Fuhrmann, S., Brossart, P., Elmaagacli, A., Goerner, M., Bernhard, H., Hoffmann, M., Raab, M.S., Blau, I.W., Hänel, M., Benner, A., Salwender, H.J., Goldschmidt, H.

Volltext

Longitudinal Fluorescence in Situ Hybridization at Primary Diagnosis and Relapse Reveals Clonal Evolution after Autologous Stem Cell Transplantation in Multiple Myeloma von Merz, Maximilian, Hielscher, Thomas, Seckinger, Anja, Hose, Dirk, Bertsch, Uta, Neben, Kai, Raab, Marc S, Blau, Igor, Lindemann, Hans Walter, Schmidt-Wolf, Ingo GH, Scheid, Christof, Haenel, Mathias, Weisel, Katja, Goldschmidt, Hartmut, Jauch, Anna, Hillengass, Jens

Volltext

Impact of Severe Infections during Induction Therapy on Dosage, Response and Survival in Newly Diagnosed Multiple Myeloma - a Subgroup Analysis from the Randomized Phase III Trial... von Mai, Elias Karl, Kunz, Christina, Bertsch, Uta, Salwender, Hans-Juergen, Pfreundschuh, Michael, Duehrsen, Ulrich, Brossart, Peter, Peter, Norma, Neben, Kai, Hielscher, Thomas, Hillengass, Jens, Martin, Hans, Lindemann, Hans Walter, Scheid, Christof, Weisel, Katja C., Blau, Igor W., Goldschmidt, Hartmut

Volltext

Capecitabine (Cape) versus 5-fluorouracil (5-FU)–based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III... von Hofheinz, R., Wenz, F. K., Post, S., Matzdorff, A., Laechelt, S., Hartmann, J. T., Müller, L., Link, H., Moehler, M. H., Kettner, E., Fritz, E., Hieber, U., Lindemann, H. W., Grunewald, M., Kremers, S., Constantin, C., Hipp, M., Gencer, D., Burkholder, I., Hochhaus, A.

Volltext

Spectrum of outcome in infants with extreme neonatal jaundice von HANKØ, E, LINDEMANN, R, HANSEN, T. W. R

Volltext

In-plane quasi-single-domain BaTiO3 via interfacial symmetry engineering von Lee, J. W., Eom, K., Paudel, T. R., Wang, B., Lu, H., Huyan, H. X., Lindemann, S., Ryu, S., Lee, H., Kim, T. H., Yuan, Y., Zorn, J. A., Lei, S., Gao, W. P., Tybell, T., Gopalan, V., Pan, X. Q., Gruverman, A., Chen, L. Q., Tsymbal, E. Y., Eom, C. B.

Volltext

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final res... von Rödel, Claus, Prof, Graeven, Ullrich, MD, Fietkau, Rainer, Prof, Hohenberger, Werner, Prof, Hothorn, Torsten, Prof, Arnold, Dirk, Prof, Hofheinz, Ralf-Dieter, Prof, Ghadimi, Michael, Prof, Wolff, Hendrik A, MD, Lang-Welzenbach, Marga, MSc, Raab, Hans-Rudolf, Prof, Wittekind, Christian, Prof, Ströbel, Philipp, Prof, Staib, Ludger, Prof, Wilhelm, Martin, Prof, Grabenbauer, Gerhard G, Prof, Hoffmanns, Hans, MD, Lindemann, Fritz, MD, Schlenska-Lange, Anke, MD, Folprecht, Gunnar, Prof, Sauer, Rolf, Prof, Liersch, Torsten, Prof

Volltext

Microstructural design and mechanical properties of a cast and heat-treated intermetallic multi-phase γ-TiAl based alloy von Schwaighofer, Emanuel, Clemens, Helmut, Mayer, Svea, Lindemann, Janny, Klose, Joachim, Smarsly, Wilfried, Güther, Volker

Volltext